Opinion
Case No. 3:11-cv-00840 JCS Case No. 3:11-cv-01609 JCS Case No. 3:11-cv-01610 JCS
10-25-2011
TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs, v. HANDA PHARMACEUTICALS, LLC, Defendant. TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs, v. ANCHEN PHARMACEUTICALS, INC., AND TWI PHARMACEUTICALS, INC., Defendants. TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs, v. IMPAX LABORATORIES, INC., Defendant.
TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS LLC, AND TAKEDA PHARMACEUTICALS AMERICA, INC. By: Jeffrey I. Weinberger (SBN 056214) Ted G. Dane (SBN 143195) Heather E. Takahashi (SBN 245845) MUNGER, TOLLES & OLSON LLP HANDA PHARMACEUTICALS, LLC By: William R. Zimmerman (SBN 195859) Steven A. Maddox (pro hac vice) KNOBBE, MARTENS, OLSON & BEAR, LLP Payson J. LeMeilleur (SBN 205690) KNOBBE, MARTENS, OLSON & BEAR, LLP ANCHEN PHARMACEUTICALS, INC. AND TWI PHARMACEUTICALS, INC. By: Don J. Mizerk (SBN 208477) HUSCH BLACKWELL LLP IMPAX LABORATORIES, INC. By: David C. Doyle (SBN 70690) Eric M. Acker (SBN 135805) MORRISON & FOERSTER LLP Brian F. McMahon (SBN 235373) MORRISON & FOERSTER LLP Parisa Jorjani (SBN 203487) MORRISON & FOERSTER LLP Attorneys for Defendant IMPAX LABORATORIES, INC.
STIPULATION TO PAGE LIMITS ON CLAIM CONSTRUCTION BRIEFING; [PROPOSED] ORDER THEREON
Judge: Hon. Joseph C. Spero
Plaintiffs Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals LLC, and Takeda Pharmaceuticals America, Inc. (collectively, "Takeda"), and Defendants Handa Pharmaceuticals, LLC ("Handa"), Anchen Pharmaceuticals, Inc. ("Anchen"), TWi Pharmaceuticals, Inc. ("TWi"), and Impax Laboratories, Inc. ("Impax") (collectively, "Defendants"), hereby stipulate through their respective attorneys as follows:
WHEREAS, on October 14, 2011, the Court ordered the parties to meet and confer and submit a proposal on the number of briefs and page limits for the Claim Construction;
WHEREAS, the parties have met and conferred; NOW THEREFORE, IT IS HEREBY STIPULATED that, subject to the Court's approval, the number of briefs and page limits for Claim Construction shall be as follows:
- Takeda shall file one opening brief, not to exceed 30 pages of text, on November 4, 2011;Respectfully Submitted,
- Defendants shall file one joint brief in response, not to exceed 30 pages of text, on November 23, 2011; and
- Takeda shall file one reply brief on December 14, 2011. Pursuant to Local Rule 7-4(b), Takeda presently anticipates filing a reply brief of no more than 15 pages.
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.
By: Jeffrey I. Weinberger (SBN 056214)
Ted G. Dane (SBN 143195)
Heather E. Takahashi (SBN 245845)
MUNGER, TOLLES & OLSON LLP
HANDA PHARMACEUTICALS, LLC
By: William R. Zimmerman (SBN 195859)
Steven A. Maddox (pro hac vice)
KNOBBE, MARTENS, OLSON & BEAR, LLP
Payson J. LeMeilleur (SBN 205690)
KNOBBE, MARTENS, OLSON & BEAR, LLP
ANCHEN PHARMACEUTICALS, INC. AND
TWI PHARMACEUTICALS, INC.
By: Don J. Mizerk (SBN 208477)
HUSCH BLACKWELL LLP
IMPAX LABORATORIES, INC.
By: David C. Doyle (SBN 70690)
Eric M. Acker (SBN 135805)
MORRISON & FOERSTER LLP
Brian F. McMahon (SBN 235373)
MORRISON & FOERSTER LLP
Parisa Jorjani (SBN 203487)
MORRISON & FOERSTER LLP
Attorneys for Defendant
IMPAX LABORATORIES, INC.
Filer's Attestation
I, Heather Takahashi, am the ECF user whose identification and password are being used to file this STIPULATION TO PAGE LIMITS ON CLAIM CONSTRUCTION BRIEFING In compliance with General Order 45.X.B, I hereby attest that the other above-named signatory concurs in this filing.
PURSUANT TO STIPULATION, IT IS SO ORDERED.
Judge Joseph C. Spero 14328274.1